Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

ICD-10 coalition grows again

The Healthcare Leadership Council , a coalition of healthcare chief executives from all disciplines within the U.S. healthcare industry, is the latest organization to join the Coalition for ICD-10 and advocate for U.S. adoption of the ICD-10 coding standard in 2015.

Analysis challenges argument in favor of repealing the medical device tax

An analysis from the Congressional Research Service challenges a common talking point among legislators that the medical device tax destroys jobs and encourages manufacturers to operate oversees, according to The New York Times. 

Protesting the ACA

Some U.S. consumers are turning down tax credits offered through the Affordable Care Act out of principle, opting to spend more on health insurance, reports U.S. News & World Report.

Lawmakers look to repeal medical device tax

Momentum is building in Congress to repeal the medical device tax.

Legislators look to repeal medical device tax

Momentum is growing in Congress to repeal taxes on medical device sales, reports The Hill.

Thumbnail

Medicare's policy not to pay for HACs appears to be working

Medicare's policy not to pay for the treatment of hospital-acquired infections appears to be making an impact, according to Medscape.   

Harvard feels consequences of own ideas on healthcare reform

Harvard faculty are in an uproar over rising healthcare costs, even as the school's very own economists and health policy advisors had championed heathcare reform efforts, reports The New York Times. 

Accenture wins $563M federal contract

Accenture Federal Services has won a five-year, $563 million contract to continue its work on Healthcare.gov, reports Clinical Innovation + Technology.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.